Substance Use Disorder

Tobacco Free

Association of Clinicians for the Underserved | Inspired by expert recommendations, Tobacco Free brings you information and resources on the most effective tobacco use interventions for underserved patients, including office systems, motivational interventions and pharmacotherapy. Download Research (Link)

Tobacco Free Read More >>

Waiver Elimination (MAT Act): Notification of Intent to use Schedule III, IV or V Opioid Drugs

Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use disorder (OUD). With this provision, and effective immediately, SAMHSA will no longer be accepting NOIs (waiver

Waiver Elimination (MAT Act): Notification of Intent to use Schedule III, IV or V Opioid Drugs Read More >>

Scroll to Top